logo

UroGen Pharma Ltd Inc. (URGN) Price Performance: The Role of Share Buybacks and Stock Splits

DOYU

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -31.36%. However, over the past six months, we’ve seen a stronger performance of -40.81%. The price of URGN leaped by -29.64% over the last 30 days. And in the last five days, it has fallen by -29.58%.

The market performance of UroGen Pharma Ltd’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $20.70 on 06/14/24, while the lowest value for the same duration was $8.94 on 05/16/25.

52-week price history of URGN Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. UroGen Pharma Ltd’s current trading price is -64.69% away from its 52-week high, while its distance from the 52-week low is -18.23%. The stock’s price range during this period has varied between$8.94 and $20.70. The UroGen Pharma Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 9.58 million for the day, a figure considerably higher than their average daily volume of 0.54 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

UroGen Pharma Ltd (URGN) has experienced a quarterly decline of -32.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 337.05M and boasts a workforce of 235 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.55, with a change in price of -3.40. Similarly, UroGen Pharma Ltd recorded 580,073 in trading volume during the last 100 days, posting a change of -31.75%.

URGN Stock Stochastic Average

As of today, UroGen Pharma Ltd’s raw stochastic average for the last 50 days stands at 14.38%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 15.57%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 18.21% and 27.12%, respectively.

Most Popular